Tianjin Tianyao Pharmaceuticals (600488.SH) subsidiary's Vitamin B injection has new specifications and has passed the consistency evaluation for generic drugs.

date
15:49 14/08/2026
avatar
GMT Eight
Jin Pharmaceutical Industry (600488.SH) announced that recently, its subsidiary, Hubei Jin Pharmaceutical Industry Co., Ltd., received the "Notice of Approval for Supplementary Drug Application" for Vitamin B Injection, issued by the National Medical Products Administration. This approval allows for the addition of a new specification of 1ml: 0.1g and the product has passed the consistency evaluation of generic drug quality and efficacy (referred to as "consistency evaluation"). This medication is suitable for the prevention and treatment of Vitamin B deficiency.
Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Hubei Tianjin Tianyao Pharmaceuticals Co., Ltd., has received the "Notice of Approval for Drug Supplement Application" issued by the National Medical Products Administration, which approves the addition of a new specification of 1ml: 0.1g for Vitamin B injection and the consistency evaluation of the quality and efficacy of the generic drug (referred to as "consistency evaluation"). This drug is indicated for the prevention and treatment of Vitamin B deficiency.